Pfizer's (NYSE: PFE) management team is confident in its 2025 opportunities. Where to invest $1,000 right now? Our analyst ...

Let’s dig into the relative performance of Corcept (NASDAQ:CORT) and its peers as we unravel the now-completed Q1 branded ...

Eleven-year follow-up data continue to show the invasive disease-free survival benefit for node-positive patients seen in previous analyses.

Dow Jones Top Company Headlines at 1 PM ET: New Allegations About Timing of Pfizer Covid Vaccine Passed to House Panel | Walmart ... New Allegations About Timing of Pfizer Covid Vaccine Passed to ...

Stock futures soared on Monday after a trade deal to substantially lower tariffs was reached with China over the weekend. According to a joint statement, Trump's "reciprocal" tariffs on China will ...

Shares of Alphamab Oncology plunged 14.4% to HK$6.28, leading declines in Hong Kong-listed pharmaceutical stocks.Meanwhile, ...

Pfizer’s recent stock action has shown a modest uptick, but Wall Street analysts see bigger things ahead. The average price target of $28.52 implies a 25% upside from its current $22.79 perch.

Protalix BioTherapeutics, Inc.’s PLX share price has dipped by 35.47%, which has investors questioning if this is right time to buy.

Pfizer's PFE stock has risen 5% since it reported first-quarter results on April 29. While the company beat estimates for earnings, it missed the same for sales. Earnings of 92 cents per share rose 12 ...